BioSpace News Archive

Entera Bio Ltd. today reported corporate updates and financial results for the first quarter ended March 31, 2023.

Atara Biotherapeutics, Inc. today reported the grant of 6,250 restricted stock units of Atara’s common stock to one newly hired employee.

Savara Inc. today announced the grant of inducement awards to two new employees.

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on April 24, 2023, the Compensation Committee of Acadia’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 98,850 shares of common stock and 59,934 restricted stock units (“RSUs”) to 44 new employees under Acadia’s 2023 Inducement Plan.

ORIC Pharmaceuticals, Inc. today announced that on May 1, 2023 (the “Grant Date”), ORIC granted a total of 29,800 non-qualified stock options and 4,980 restricted stock units to two new non-executive employees who began their employment with ORIC in April 2023.

Regulatory News: Aptorum Group Limited today announced that it has received a letter from the Nasdaq Stock Market LLC (“Nasdaq”) Listing Qualifications Department notifying the Company that it is not currently in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Global Market. Nasdaq Listing Rule 5450(b)(1)(A).

Acurx Pharmaceuticals, Inc. announced today that the Company will discuss its first quarter 2023 financial results on Friday, May 12, 2023 , at 8:00 am ET before the U.S. financial markets open.

Fulcrum Therapeutics, Inc. today announced that the Company granted non-statutory stock options to new employees.